Evidence map›Paper›PMID 20189813›Full record

ArticleBioorganic & medicinal chemistry2010

Chemical biology studies on norrisolide.

Gianni Guizzunti, Thomas P Brady, Derek Fischer, Vivek Malhotra, Emmanuel A Theodorakis

Open access · greenAbstract read
In one paragraph

Article in Bioorganic & medicinal chemistry, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Gianni GuizzuntiDepartment of Cell and Developmental Biology, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093, USA.
Thomas P BradyDepartment of Chemistry and Biochemistry, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0358, USA.
Derek FischerDepartment of Chemistry and Biochemistry, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0358, USA.
Vivek MalhotraDepartment of Cell and Developmental Biology, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093, USA.
Emmanuel A TheodorakisDepartment of Chemistry and Biochemistry, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0358, USA.
University of California, San Diego · US

Funding

MECHANISM OF GOLGI BREAKDOWN DURING MITOSISR01GM046224 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MALHOTRA, VIVEK · 1991 to 2007
$2.7M
Synthesis of Bioactive Marine Natural ProductsR01GM081484 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI THEODORAKIS, EMMANUEL A · 2008 to 2011
$1.2M
NIGMS NIH HHS GM 081484NIGMS NIH HHS GM 46224NIGMS NIH HHS R01 GM046224NIGMS NIH HHS R01 GM081484
6 · The paper itself

Abstract

The cellular activity of norrisolide (7), a novel Golgi-vesiculating agent, was dissected as function of its chemical structure. This natural product induces irreversible vesiculation of the Golgi membranes and blocks protein transport at the level of the Golgi. The Golgi localization and fragmentation effects of 7 depend on the presence of the perhydroindane core, while the irreversibility of fragmentation depends on the acetyl group of 7. We show that fluorescent derivatives of norrisolide are able to localize to the Golgi apparatus and represent important tools for the study of the Golgi structure and function.

Indexed as

AnimalsCells, CulturedDiterpenesDrug DesignGolgi ApparatusIntracellular MembranesMembrane ProteinsMolecular StructureProtein TransportRatsStereoisomerismStructure-Activity RelationshipDiterpenesMembrane Proteinsnorrisolide

Identifiers

PMID20189813
PMCPMC2838712
OpenAlexW2124800424

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.